XML 36 R22.htm IDEA: XBRL DOCUMENT v3.19.1
Note 14 - Net (Loss) Income Per Share
12 Months Ended
Dec. 31, 2018
Notes to Financial Statements  
Earnings Per Share [Text Block]
1
4
. Net
(Loss)
Income
Per Share
 
Our basic net (loss) income per share attributable to Progenics amounts have been computed by dividing net (loss) income attributable to Progenics by the weighted-average number of common shares outstanding during the period. For
2018
and
2017
we reported net losses and, accordingly, potential common shares were
not
included since such inclusion would have been anti-dilutive. As a result, basic and diluted EPS are the same for
2018
and
2017.
For
2016,
we reported net income, and the computation of diluted earnings per share is based upon the weighted-average number of our common shares and dilutive effect of stock options (determined using the treasury stock method).
 
In applying the treasury stock method for the calculation of diluted EPS, amounts of unrecognized compensation expense are required to be included in the assumed proceeds in the denominator of the diluted EPS calculation unless they are anti-dilutive. We have made an accounting policy decision to calculate windfall tax benefits/shortfalls, for purposes of diluted EPS calculation, excluding the impact of deferred tax assets. This policy decision will apply when we have net income and windfall tax benefits/shortfalls are realizable.
 
The calculations of net (loss) income per share, basic and diluted, are as follows:
 
   
Net (loss) income
   
Weighted-average
   
 
 
 
   
attributable
   
shares
   
 
 
 
   
to Progenics
   
outstanding
   
Per share
 
   
(Numerator)
   
(Denominator)
   
amount
 
2018
 
 
 
 
 
 
 
 
 
 
 
 
Basic and diluted
  $
(67,657
)    
77,890
    $
(0.87
)
2017
 
 
 
 
 
 
 
 
 
 
 
 
Basic and diluted
  $
(51,013
)    
70,284
    $
(0.73
)
                         
2016
 
 
 
 
 
 
 
 
 
 
 
 
Basic
  $
10,806
     
70,003
    $
0.15
 
Dilutive effect of stock options
   
-
     
152
     
 
 
Diluted
  $
10,806
     
70,155
    $
0.15
 
 
The following table summarizes anti-dilutive common shares or common shares where performance conditions have
not
been met, that were excluded from the calculation of the diluted net (loss) income per share:
 
   
2018
   
2017
   
2016
 
Stock options
   
3,794
     
2,395
     
3,577
 
Contingent consideration liability
(1)
   
2,619
     
2,824
     
1,644
 
Total securities excluded
 
 
6,413
   
 
5,219
   
 
5,221
 
___________________________________
(
1
)
Calculated as follows: (a) the contingent consideration liability balance at
December 31
divided by (b) the closing stock price of our common stock on the last day of trading of the fiscal year.